News & Updates

Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021

In the treatment of patients with chronic hepatitis B (CHB), the novel tenofovir amibufenamide (TMF) is as good as tenofovir disoproxil fumarate (TDF) in terms of efficacy but with the advantage of better bone and renal safety, according to the results of a noninferiority trial.

Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021
Weight, OGTT values predict need for insulin therapy among women with GDM
Weight, OGTT values predict need for insulin therapy among women with GDM
05 Nov 2021

Pregnant women with gestational diabetes mellitus (GDM) who are overweight and have increased blood glucose, as measured by the Oral Glucose Tolerance Test (OGTT), are highly likely to require subsequent insulin therapy, according to a study.

Weight, OGTT values predict need for insulin therapy among women with GDM
05 Nov 2021